This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q2 FY27 revenue up 28%, PAT up 23%, EBITDA margin down
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended 30 Sep 2026, as the company has no subsidiaries: revenue from operations rose 28% to Rs 4,437 lakh from Rs 3,464 lakh a year earlier, and profit after tax rose 23% to Rs 1,359 lakh from Rs 1,108 lakh; EPS was Rs 4.33. EBITDA margin narrowed about 3.4 points to 41.3% from 44.7%. Half year revenue was Rs 8,224 lakh, PAT Rs 2,687 lakh and operating cash flow Rs 2,509 lakh. No exceptional items.
Revenue and profit growth supports the stock, but the narrower EBITDA margin shows cost pressure that could limit further gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹44.37 Cr | ₹34.64 Cr | +28.1% |
| Operating profit | ₹17.31 Cr | ₹14.66 Cr | +18.1% |
| Profit after tax | ₹13.59 Cr | ₹11.08 Cr | +22.7% |
| EBITDA margin | 41.3% | 44.7% | −3.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.